Analyst Ratings for Ionis Pharmaceuticals (IONS)
IONS Rating Summary
IONS Price Target Summary
- Highest: $100.00 (Piper Sandler)
- Lowest: $46.00 (UBS)
- Average: $85.05
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$85.05 (+14.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$85.05 (+14.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
95.00 (N/A) |
81.00 (74.04) |
-8.59% | Details |
| 10/8/2025 | JPMorgan | Jessica Fye | Upgrade | Overweight (Neutral) |
80.00 (49.00) |
69.02 (74.04) |
7.27% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
